Doesn't matter. The fate will be the same.
I strongly urge you to do some DD. Specifically around the corp structure and relationships between the various parties. Look at the voting shares, look at who controls the patents and how they get compensated IF they ever get anything to market, and look at the company's history of developments and objectives and communication. Then look a the actual information that was released and by whom. Look at the former collaborators that are now no longer on the payroll and no longer interested in NNVC. Look at all the 'codes throughout the years that had "laser like" focus, only to be replaced with another "flavor of the month." There is a pattern and a reason for this continual repetitive cycle. Read this board from the past 5 years, search something like Tox or clinicals or Dengue and see how we are hearing the exact same claims.
In my opinion (and I have been correct for 4 years) there will be no Tox in '16, no clinicals in '16 and no scale up completed in '16. And use Occam's razor and it is clear why that will occur.
May I ask, if that is the case, and I am once again correct, and we are chatting in 12 months, how confidant will you be in the company? I ask because there are many here who were also previous longs and bulls and now are not. History is a great teacher for those who are smart enough to listen.
Good Luck. Let's catch up again in 12 months.
News 
Market Data 
Discover 
